Luise Schlotterose

Luise Schlotterose

Auto-generated profile, based on publicly available information

Luise Schlotterose

Department of Anatomy, Kiel University, Otto-Hahn-Platz 8, 24118, Kiel, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
LSLuise Schlotterose
Luise Schlotterose
FCFrançois Cossais
François Cossais
RLRalph Lucius
Ralph Lucius
KHKirsten Hattermann
Kirsten Hattermann
Neuroinflammation is both cause and effect of many neurodegenerative disorders. Activation of astrocytes and microglia leads to the release of cytokines and reactive oxygen species followed by blood-brain barrier leakage and neurotoxicity. Transient neuroinflammation is considered to be largely protective, however, chronic neuroinflammation contributes to the pathology of Alzheimer's disease, multiple sclerosis, traumatic brain injury, and many more. In this study, we focus on the aspect of cytokine-induced neuroinflammation in human microglia and astrocytes. Here we show by mRNA and protein analysis that cytokines, released not only by microglia but also by astrocytes, lead to a circuit of proinflammatory activation. Moreover, we present how the natural compound resveratrol can stop the circuit of proinflammatory activation and facilitate return to resting conditions. These results will contribute to distinguishing between the causes and the effects of neuroinflammation, a better understanding of underlying mechanisms, and potential treatment options.

20 February 2024 in Acta Biomaterialia
Verified
Journal Article
Open access
KBKrathika Bhat
Krathika Bhat
LSLuise Schlotterose
Luise Schlotterose
LHLisa Hanke
Lisa Hanke
HHHeike Helmholz
Heike Helmholz
EQEckhard Quandt
Eckhard Quandt
RWRegine Willumeit
Regine Willumeit
Lithium (Li), a widely used drug for bipolar disorder management, is associated with many side effects due to systemic exposure. The localized delivery of lithium through implants could be an approach to overcome this challenge, for which biodegradable magnesium (Mg)-based materials are a promising choice. In this study, we focus on Mg-Li thin film alloys as potential Li-releasing implants. Therefore, we investigated the in vitro short-term corrosion behavior and cytocompatibility of two alloys, Mg-1.6wt%Li and Mg-9.5wt%Li. As glial cells are the key players of foreign body responses to implants, we used human glial cell lines for cytocompatibility studies, and a murine brain slice model for a more holistic view at the neuroinflammatory response. We found that Mg-1.6wt%Li corrodes approximately six times slower than Mg-9.5wt%Li. Microscopic analysis showed that the material surface (Mg-1.6wt%Li) is suitable for cell adhesion. The cytocompatibility test with Mg-1.6wt%Li and Mg-9.5wt%Li alloy extracts revealed that both cell types proliferated well up to 10 mM Mg concentration, irrespective of the Li concentration. In the murine brain slice model, Mg-1.6wt%Li and Mg-9.5wt%Li alloy extracts did not provoke a significant upregulation of glial inflammatory/ reactivity markers (IL-1β, IL-6, FN1, TNC) after 24 h of exposure. Furthermore, the gene expression of IL-1β (up to 3-fold) and IL-6 (up to 16-fold) were significantly downregulated after 96 h, and IL-6 downregulation showed a Li concentration dependency. Together, these results indicate the acute cytocompatibility of two Mg-Li thin film alloys and provide basis for future studies to explore promising applications of the material. STATEMENT OF SIGNIFICANCE: We propose the idea of lithium delivery to the brain via biodegradable implants to reduce systemic side effects of lithium for bipolar disorder therapy and other neurological applications. This is the first in vitro study investigating Mg-xLi thin film degradation under physiological conditions and its influence on cellular responses such as proliferation, viability, morphology and inflammation. Utilizing human brain-derived cell lines, we showed that the material surface of such a thin film alloy is suitable for normal cell attachment. Using murine brain slices, which comprise a multicellular network, we demonstrated that the material extracts did not elicit a pro-inflammatory response. These results substantiate that degradable Mg-Li materials are biocompatible and support the further investigation of their potential as neurological implants.

9 June 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
LSLuise Schlotterose
Luise Schlotterose
MPMariya Stanislavovna Pravdivtseva
Mariya Stanislavovna Pravdivtseva
Frowin EllermannFrowin Ellermann
Frowin Ellermann
OJOlav Jansen
Olav Jansen
JHJan-Bernd Hövener
Jan-Bernd Hövener
KHKirsten Hattermann
Kirsten Hattermann
The recognition of the role of microglia cells in neurodegenerative diseases has steadily increased over the past few years. There is growing evidence that the uncontrolled and persisting activation of microglial cells is involved in the progression of diseases such as Alzheimer’s or Parkinson’s disease. The inflammatory activation of microglia cells is often accompanied by a switch in metabolism to higher glucose consumption and aerobic glycolysis. In this study, we investigate the changes induced by the natural antioxidant resveratrol in a human microglia cell line. Resveratrol is renowned for its neuroprotective properties, but little is known about its direct effect on human microglia cells. By analyzing a variety of inflammatory, neuroprotective, and metabolic aspects, resveratrol was observed to reduce inflammasome activity, increase the release of insulin-like growth factor 1, decrease glucose uptake, lower mitochondrial activity, and attenuate cellular metabolism in a 1H NMR-based analysis of whole-cell extracts. To this end, studies were mainly performed by analyzing the effect of exogenous stressors such as lipopolysaccharide or interferon gamma on the metabolic profile of microglial cells. Therefore, this study focuses on changes in metabolism without any exogenous stressors, demonstrating how resveratrol might provide protection from persisting neuroinflammation.

11 April 2026 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
MDMirriam Domocos
Mirriam Domocos
DBDenis E. Bragin
Denis E. Bragin
NSNagesh C. Shanbhag
Nagesh C. Shanbhag
LSLuise Schlotterose
Luise Schlotterose
Mootaz SalmanMootaz Salman
Mootaz Salman
A functional blood–brain barrier (BBB) is essential for CNS homeostasis, and its disruption is an early feature of both acute brain injury and chronic neurodegenerative disorders. Hypoxia induces BBB breakdown by triggering endothelial dysfunction, oxidative stress, metabolic dysregulation and thrombo‐inflammatory signalling that compromise barrier integrity. However, strategies that restore BBB function remain limited. Here, we investigated whether photobiomodulation (PBM), a non‐invasive light therapy, can rescue BBB dysfunction following acute hypoxic stress. Using a multicellular in vitro BBB model comprising immortalised human brain microvascular endothelial cells, pericytes and astrocytes, we induced hypoxic injury (6 h, 1% O 2 ) and applied three PBM treatments during recovery. Hypoxia significantly reduced transendothelial electrical resistance (TEER), whereas PBM restored barrier function in endothelial monocultures and tri‐cultures. Endothelial cells exhibited the most pronounced hypoxic response, characterised by increased expression of hypoxia‐inducible factor‐1α (HIF‐1α), plasminogen activator inhibitor‐1 and von Willebrand factor (vWF), all attenuated by PBM. Importantly, small interfering RNA‐mediated knockdown of vWF partially recapitulated PBM‐induced restoration of barrier integrity, identifying endothelial vWF as a mediator of recovery. PBM also reduced reactive oxygen species in hypoxic astrocytes and pericytes, indicating co‐ordinated multicellular modulation. Together, these findings demonstrate that PBM restores BBB integrity following hypoxic insult by modulating endothelial thrombo‐inflammatory signalling at the same time as reducing oxidative stress in glial cells. Rather than acting as a non‐specific cytoprotective stimulus, PBM engages molecular pathways linked to endothelial activation. This work establishes a mechanistically informed platform for investigating BBB repair and highlights PBM as a strategy to protect vascular integrity in hypoxia‐associated neurological disorders. image Key points: Hypoxia is a major driver of blood–brain barrier (BBB) dysfunction, yet there are currently no targeted therapies that directly restore barrier integrity. Photobiomodulation (PBM) is a non‐invasive low‐level light intervention known to facilitate mitochondrial function and cellular stress responses. In a human in vitro BBB model, repeated PBM treatment restored transendothelial electrical resistance (TEER) 24 and 48 h after hypoxic injury, with endothelial rescue linked to downregulation of von Willebrand factor (vWF). PBM modulated oxidative stress, hypoxia signalling and thrombo‐inflammatory pathways across endothelial cells, astrocytes and pericytes. These findings support PBM‐driven modulation of endothelial signalling as a potential strategy to restore BBB integrity in hypoxia‐associated neurological conditions.

1 January 2026 in Bioactive Materials
Verified
Journal Article
Open access
MKMishal Khan
Mishal Khan
PKPhilipp Kollenz
Philipp Kollenz
MFMaret Fritzenschaft
Maret Fritzenschaft
FTFereydoon Taheri
Fereydoon Taheri
FCFederico Colombo
Federico Colombo
CSChristine Selhuber-Unkel
Christine Selhuber-Unkel
Glioblastoma (GB) is one of the most aggressive and lethal brain tumors, characterized by rapid proliferation, diffuse infiltrative growth, therapeutic resistance, and molecular heterogeneity. A major challenge in studying GB is the lack of in vitro models that accurately replicate the tumor's cellular characteristics observed in vivo, particularly the importance of three-dimensional (3D) models. This study investigated the traction stress exerted by LN229 and T98G human GB cell lines, as well as the HMC3 human microglia cell line, using traction force microscopy. First, cells were cultured on two-dimensional (2D) collagen-coated surfaces and within three-dimensional (3D) collagen-based bioactive matrices. Afterward, these cells were extracted and reseeded on flat polyacrylamide gels coated with collagen type I to perform traction force microscopy, thereby directly probing the mechanical memory imparted by their prior 2D or 3D environments. Our findings reveal that GB cells exert substantially higher traction stresses when cultured on 2D collagen-coated surfaces compared to those cultured in 3D bioactive matrices. This underscores the relevance of protein-based bioactive materials, such as collagen scaffolds, in replicating in vivo tumor microenvironments to study GB behavior. Single-cell nanoindentation and focal adhesions quantification were performed to offer mechanistic insights into glioblastoma and microglia cells. Interestingly, in addition to notable differences in traction stresses between cells cultured in 2D and 3D collagen environments, glioblastoma showed significant variation based on the cell type in terms of single-cell stiffness and focal adhesion metrics. These findings underscore the importance of complementary biophysical assays and realistic 3D bioactive matrices when studying GB mechanics in vitro.

20 February 2026 in Chem & Bio Engineering
Verified
Journal Article
Open access
THTorge Hartig
Torge Hartig
LSLuise Schlotterose
Luise Schlotterose
GAGrace Atteh
Grace Atteh
ATAlexandrina Turcanu
Alexandrina Turcanu
AMAtharva Markale
Atharva Markale
SSStefan Schröder
Stefan Schröder
The development of 3D scaffolds addresses a critical gap in neural tissue modeling by mimicking the physiological architecture in brain cell culture. This is a key challenge to improve the reliability of in vitro assays and reduce animal testing, but also mandatory for the successful engineering of neural tissues in the future. Recently various types of applicable scaffolds have been applied for 3D cell cultures, which are typically porous hydrogels or fibrous mats produced by electrospinning. These scaffold materials oftentimes have a 3D structure limiting the ingrowth of cells and the diffusion of biophysical factors throughout the material. In this study, we show the capability of Aerohydrogels, fabricated via initiated chemical vapor deposition, to allow biophysical communication throughout the material in a spatially divided brain cell coculture of microglia and astrocytes. The recently developed Aerohydrogels have an ultralow density and mechanically stable 3D hollow fibrous structure. The analysis of Interleukin inflammatory pathways shows the protective influence of astrocytes within the coculture by intercellular communication. The findings support the great applicability of the newly applied Aerohydrogels in 3D brain cell coculture and relevant analysis methods like live cell imaging, cell viability assays, or gene expression. This successful establishment allows more dedicated future applications and optimization of Aerohydrogels in neural tissue modeling.